Research Options:

Week of Expected Pricing 11/4/2021
Company Name EVOTEC AG
Proposed Ticker EVO
CUSIP 45174G109
Business Description We are an industry-leading drug discovery and development partner for the pharmaceutical and biotechnology industry. Our mission is to discover best and first-in-class medicines for a broad range of difficult to treat diseases in collaboration with our partners.
Lead Underwriter BofA Securities, Inc, Morgan Stanley & Co. LLC
Co-Managers Citigroup Capital Markets Inc, Cowen and Company, LLC, Jefferies LLC, RBC Capital Markets, LLC
Initial Shares 2,00,00,000
Revised Initial Shares N/A
Initial Price $21.75-$21.75
Revised Price N/A
Final Price $21.75
Final Ticker EVO

 

 

   
  © 2024 ICE Data Services. All rights reserved.